Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Agilent Technologies logoAgilent Technologies A

Agilent Technologies said net revenue for the three months ended January 31, 2025 was $1,681 million, up 1% from the same period last year, and net income was $318 million compared to $348 million in the prior-year period.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Agilent Technologies said net revenue for the three months ended January 31, 2025 was $1,681 million, up 1% from the same period last year, and net income was $318 million compared to $348 million in the prior-year period.

  2. The company said foreign currency movements for the three months had an unfavorable impact of 2 percentage points on revenue growth, with Life Sciences and Diagnostics Markets revenue up 4%, Agilent CrossLab revenue up 1%, and Applied Markets revenue down 4%.

  3. Agilent said cash provided by operating activities for the three months ended January 31, 2025 was $431 million, below $485 million in the same period last year, and cash and cash equivalents as of January 31, 2025 were $1,467 million.

  4. The company said it repurchased and retired 649,857 shares for $90 million under the 2023 repurchase program during the three months, with remaining authorization of approximately $284 million, and paid cash dividends of $0.248 per share, or $71 million in total.

Key figures

Quarter ended January 31, 2025

Revenue
$1.7B
Operating income
$376M
Net income
$318M
EPS
$1.11
Operating cash flow
$431M

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Quarterly Net Revenue $1,681 million, Net Income $318 million

Agilent Technologies said net revenue for the three months ended January 31, 2025 was $1,681 million, up 1% from the same period last year, and net income was $318 million compared to $348 million in the prior-year period.

Source · Based on the MD&A text of the filing

Foreign Currency Impact and Revenue Changes by New Segment

The company said foreign currency movements for the three months had an unfavorable impact of 2 percentage points on revenue growth, with Life Sciences and Diagnostics Markets revenue up 4%, Agilent CrossLab revenue up 1%, and Applied Markets revenue down 4%.

Source · Based on the MD&A text of the filing

Three-Month Operating Cash Flow $431 million

Agilent said cash provided by operating activities for the three months ended January 31, 2025 was $431 million, below $485 million in the same period last year, and cash and cash equivalents as of January 31, 2025 were $1,467 million.

Source · Based on the MD&A text of the filing

2023 Repurchase Program Execution and Dividends

The company said it repurchased and retired 649,857 shares for $90 million under the 2023 repurchase program during the three months, with remaining authorization of approximately $284 million, and paid cash dividends of $0.248 per share, or $71 million in total.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.